Most Read Articles
Stephen Padilla, 2 days ago
The novel coronavirus disease (COVID-19) pandemic appears to have a significant impact on oncological care, according to a study, which stresses the need for psycho-oncological support for cancer patients.
01 Aug 2020
Supplementation with probiotics may have positive effects in patients with type 2 diabetes mellitus (T2DM), reports a recent meta-analysis.
01 Aug 2020
Ensituximab, a chimeric monoclonal antibody targeting a variant of MUC5AC, shows modest clinical activity with good safety profile in patients with refractory colorectal cancer, according to data from a phase II study.
Roshini Claire Anthony, 30 Jul 2020

Frailty may indicate an increased risk of death from COVID-19, results of the COPE* study showed.

Patients with idiopathic inflammatory myopathies at high risk of acute coronary syndrome

20 Nov 2019

The risk of acute coronary syndrome (ACS) is increased in individuals with idiopathic inflammatory myopathies (IIM), especially within the first year following diagnosis, according to a recent study.

The incidence rate of ACS was higher in IIM patients than in the general population, specifically among older individuals and within the first year of diagnosis. The overall incidence rate of ACS in IIM was 15.6 (95 percent confidence interval [CI], 11.7–20.4) per 1,000 person-years. Compared with the general population, those with IIM had a hazard ratio of 2.4 (95 percent CI, 1.8–3.2).

The increased risk of ACS in IIM individuals persisted even after accounting for the competing risk of death, with a cumulative incidence of 7 percent at 5 years compared to 3.3 percent in the general population.

This study sought to examine the risk of ACS in an IIM cohort vs the general Swedish population. The investigators identified 655 individuals with incident IIM and 6,813 general population comparators from national registries. IIM individuals were diagnosed between 2002 and 2011. Follow-up began at IIM diagnosis and corresponding date in the general population.

The International Classification of Diseases codes were used to define ACS, cardiovascular (CV) comorbidities and CV risk factors. The risk of ACS in IIM patients was compared with that in the general population using Cox proportional hazards models. Competing risk regression models were used to account for the competing risk of death.

“Evidence suggests an increased risk of CV diseases, including ACS, in IIM,” the investigators noted.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Stephen Padilla, 2 days ago
The novel coronavirus disease (COVID-19) pandemic appears to have a significant impact on oncological care, according to a study, which stresses the need for psycho-oncological support for cancer patients.
01 Aug 2020
Supplementation with probiotics may have positive effects in patients with type 2 diabetes mellitus (T2DM), reports a recent meta-analysis.
01 Aug 2020
Ensituximab, a chimeric monoclonal antibody targeting a variant of MUC5AC, shows modest clinical activity with good safety profile in patients with refractory colorectal cancer, according to data from a phase II study.
Roshini Claire Anthony, 30 Jul 2020

Frailty may indicate an increased risk of death from COVID-19, results of the COPE* study showed.